NBR1 Activators

NBR1 (Neighbor of BRCA1 gene 1) is a protein intricately linked with autophagy, a cellular mechanism responsible for degrading and recycling cellular components. As a focal player in selective autophagy, NBR1 functions as a cargo receptor, ensuring the targeted removal of specific cellular entities. The chemical landscape influencing NBR1 primarily revolves around molecules that modulate autophagy, either directly or indirectly, thus affecting the dynamics of NBR1.

Among these chemicals, Rapamycin and Torin 1, both mTOR inhibitors, stand out for their ability to induce autophagy. mTOR, a master regulator of cell growth and metabolism, when inhibited, paves the way for increased autophagic processes. By this mechanism, NBR1's activity within the autophagy pathway can be enhanced. Chloroquine and Bafilomycin A1, on the other hand, interfere with autophagosome-lysosome fusion, a crucial step in the autophagy process. These agents, by modulating this step, indirectly influence NBR1's role. Another noteworthy category includes compounds like 3-MA, Wortmannin, and LY294002, all of which inhibit specific forms of phosphoinositide 3-kinases (PI3Ks), known modulators of autophagy. The induction of autophagy by Lithium, through the inhibition of inositol monophosphatase, further expands the chemical toolbox affecting NBR1. Additionally, Spautin-1, which promotes the degradation of Vps34 PI3K complexes, and Trehalose, a disaccharide sugar, can also induce autophagy. Finally, Verapamil, a calcium channel blocker, and Metformin, an AMPK activator, both promote autophagy, thereby influencing the function of proteins, including NBR1, within this intricate pathway.